Le Lézard
Classified in: Health, Science and technology, Business
Subjects: WOM, VEN, BLK

Health In Her HUE Announces $3 Million In Funding


Health tech startup connects Black women and women of color with culturally sensitive and responsive healthcare providers and content.

NEW YORK, Jan. 8, 2024 /PRNewswire/ -- Health In Her HUE, the premier digital health platform aimed at reducing racial health disparities for Black women and women of color through technology, media and community today announced that the company has raised a $3 million seed funding round to fuel its growth by investing in talent and building out new programs and products. The funding was led by Seae Ventures and included participation from Johnson & Johnson Impact Ventures (an impact fund within the Johnson & Johnson Foundation), Morgan Stanley Inclusive Ventures Lab, Genius Guild, HBCU Founders Fund, Stanford Impact Fund and a select group of angel investors.

Health In Her HUE was formed in 2018 to connect Black women and women of color with culturally sensitive and responsive healthcare providers and content to support them with accessing better care to improve outcomes. The company was founded by CEO Ashlee Wisdom who brings over a decade of experience working across the healthcare industry in a range of leadership roles.

Health In Her HUE's platform provides its nearly 13,000 members with access to a suite of solutions to support their healthcare journey. The platform's current offerings include:

"I'm proud of the impact Health In Her HUE has achieved thus far to ensure Black women and women of color have a safe space to prioritize their holistic health and well-being," said Wisdom. "I know first-hand the challenges women of color face to receive equal quality of care while not feeling seen and heard by the healthcare system. Health In Her HUE is uniquely positioned to address the existing racial health disparities and connect our members with providers who are committed to hearing and understanding their unique lived experiences, while providing quality care accordingly."

"Ashlee's passion and vision for connecting Black women and women of color to culturally competent care is what drew our attention initially. Her focus on this vision, and ability to create a community, a team and a platform to make this vision a reality is what keeps us excited about Health In Her HUE and Ashlee's leadership. We were thrilled to lead this round of financing and look forward to continuing to support Ashlee on this journey to help more Black women and women of color access the health care providers, services and resources that are committed to their health and well-being," said Arianne Kidder, a Partner at Seae Ventures.

This marks Health In Hue HUE's second round of funding. In 2021, the company initially raised $1.2M in a pre-seed round to develop the platform. To date, the company's total investment amounts to $4.2M.

About Health In Her HUE
Health In Her HUE is the premier digital platform that connects Black women and women of color to culturally sensitive healthcare providers and offers health information and content that centers their lived experiences in order to reduce racial health disparities by leveraging the power of technology, media and community to improve health outcomes. Learn more at: healthinherhue.com and connect with us on facebook.com/healthinherhue, instagram.com/healthinherhue, linkedin.com/company/health-in-her-hue, twitter.com/healthinherhue

About Seae Ventures
Seae Ventures is an investment firm specializing in early-stage healthcare technology and services companies and focuses primarily on funding diverse entrepreneurs including women and those who identify as black, indigenous, and people of color. To date, it has deployed capital into 18 start- up companies, many of which focus specifically on solutions for underserved populations. www.seaeventures.com

SOURCE Health In Her HUE Inc


These press releases may also interest you

at 01:00
REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend the annual and the extraordinary shareholders'...

at 00:16
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an EB virus-related mRNA...

at 00:00
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101...

9 mai 2024
TCI Group is proud to be participating in Phase 1 of the Alliance for Water Stewardship (AWS) Impact Accelerator. Together we are working in Shanghai Jinshan with AWS Members and five other facilities to expand our knowledge, skills and networks to...

9 mai 2024
A research team led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded approximately $11 million over five years by the National...

9 mai 2024
Celltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale acquisition cost (WAC). Adalimumab-aaty will be...



News published on and distributed by: